Otamixaban in acute coronary syndromes

Lancet. 2009 Sep 5;374(9692):762-4. doi: 10.1016/S0140-6736(09)61529-4. Epub 2009 Aug 28.
No abstract available

Publication types

  • Comment

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Angioplasty, Balloon, Coronary
  • Anticoagulants / therapeutic use
  • Clinical Trials, Phase II as Topic
  • Cyclic N-Oxides / metabolism
  • Cyclic N-Oxides / pharmacology
  • Cyclic N-Oxides / therapeutic use*
  • Drug Monitoring
  • Heparin / therapeutic use
  • Hirudins
  • Humans
  • Metabolic Clearance Rate
  • Patient Selection*
  • Peptide Fragments / therapeutic use
  • Pyridines / metabolism
  • Pyridines / pharmacology
  • Pyridines / therapeutic use*
  • Recombinant Proteins / therapeutic use

Substances

  • Anticoagulants
  • Cyclic N-Oxides
  • Hirudins
  • Peptide Fragments
  • Pyridines
  • Recombinant Proteins
  • Heparin
  • otamixaban
  • bivalirudin